Professional Documents
Culture Documents
Ultra-Low Power Microcontrollers for Portable, Wearable, and Implantable Medical Electronics
Srinivasa R. Sridhara
MCU Development, Texas Instruments, Inc., 12500 TI Blvd, M/S 8661, Dallas, TX 75243, USA. E-mail: sridhara@ti.com. Phone: +1 214 567 9247
Abstract - An aging population, coupled with choices on diet and lifestyle, is causing an increased demand for portable, wearable, and implantable medical devices that enable chronic disease management and wellness assessment. Battery life specifications drive the power consumption requirements of integrated circuits in these devices. Microcontrollers provide the right combination of programmability, cost, performance, and power consumption needed to realize such devices. In this paper, we describe microcontrollers that are enabling todays medical applications and discuss innovations necessary for enabling future applications with sophisticated signal processing needs. As an example, we present the design of an embedded microcontroller system-on-chip that achieves the first sub-microwatt per channel electroencephalograph (EEG) seizure detection.
11 2 33445 6 8 7 5 76
AM AM /PM /PM
mg mg /dL /dL
32 kHz 16-bit CPU 60kB Flash MSP LCD FGSegs 4 xxx 128 Contrast Control RTC
SPI USCI_A1
2kB - RAM CR2032 BOR & SVS 16-bit Timer A 16-bit Timer B
CC1100 or CC2500
USB
Basic Timer
DEBUG
I.
Introduction
Medical electronics that enable chronic disease management, preventive healthcare, and wellness assessment have become a reality [1]-[3]. These devices include portable devices such as blood glucose meters, wearable devices such as continuous health monitors, and implantable devices such as pacemakers. Microcontrollers (MCUs) provide the right combination of features to enable this class of medical electronics [2]. A key feature for integrated circuits in personal health devices is power consumption. Battery life of these devices determines both the form factor and the ownership cost. Reducing the size and the cost leads to more widespread use of preventive health management devices, which in turn leads to reduction in fatalities due to preventable diseases. MCUs have ultra low-power consumption compared to other programmable processors. MCUs with 16-bit datapath and system power consumption as low as 160 A/MHz are available [4]. Though application specific integrated circuits can achieve lower power consumption, they lack programmability needed for mapping different medical algorithms. Families of 16-bit and 32-bit MCUs are available to match memory and performance needs of various medical applications [2]. Despite such excellent power consumption characteristics, battery life requirements of many implantable devices are not satisfied by todays MCUs. For example, an implantable medical SoC needs to consume less than 10 A on average, if it needs to operate for 10 years on a single 1 A-hour battery. Such ultra-low power operation cannot be achieved in todays devices with sophisticated signal processing needs.
Meeting these power levels will open a large opportunity for advanced therapy in severely debilitating illnesses. Achieving such ultra-low power consumption requires innovations in all aspects of the design of MCUs including system architecture, microarchitecture, circuit design, digital implementation, and process selection. In this paper, we describe the design of an embedded MCU system-on-chip (SoC) that incorporates novel system architecture with low-voltage operation in an ultra low-leakage process. An electroencephalograph (EEG) seizure detection application with less than 1 W power consumption is demonstrated on the MCU [5]. The rest of the paper is organized as follows. In Section II, we introduce MCUs that are enabling todays medical applications. In Section III, we present the system architecture innovations needed for the next generation MCU. In Section IV, we describe the circuit innovations required for low voltage operation. In Section V, we discuss the design of the medical platform MCU and present results from the implementation of the EEG seizure detection application. In Section VI, we conclude with a summary of the work.
556
6D-2
from the test strip to a voltage. This OA is shut down for power management when not used. The voltage output of the OA is measured by MSP430s internal 16-bit ADC. The ADC also has an internal temperature sensor. This is used to measure the local temperature, which is required in determining the accurate glucose level. The glucose level is calculated and displayed on the LCD. A portion of the on-chip Flash memory can be used to data-log the patients glucose measurements. MSP430 operates in low-power mode running an embedded real-time clock consuming approximately 1 A [4]. The static LCD is always on, and consumes an additional 0.8 A. In total, the application runs in standby under 2 A. A glucose measurement is made 46 times a day and lasts less than 1 minute. This means that the active duty cycle is very low and has little effect on the total current consumption. The total system standby current of 2 A will allow the instrument to operate from a CR2032 220-mAh coin cell battery for over 10 years. As seen in this application, a feature of many portable medical devices is that they are intermittently used. Active duty cycle and, hence, active current consumption is very low in intermittent usage. However, there are other applications such as wearable health monitors and implantable devices that require continuous operation. For such applications, active power reduction can be achieved by a combination of system architecture innovation and low-voltage operation.
needed for the voltage range of interest. As an example, Fig. 2 shows the relative energy consumption of several FFT implementation options as a function of supply voltage. The FFT implementation options differ in the number cycles taken to complete an FFT butterfly. Though both 2-cycle and 4-cycle achieve the best energy above the minimum energy point, 4-cycle FFT is preferred as it has lower area.